UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Redox phospholipidomics of enzymatically generated oxygenated phospholipids as specific signals of programmed cell death

Free radical biology & medicine, 2020-02, Vol.147, p.231-241

2020

Volltextzugriff (PDF)

Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer

The Journal of immunology (1950), 2001-01, Vol.166 (1), p.678-689

2001

Volltextzugriff (PDF)

Mechanisms and functional significance of tumour-induced dendritic-cell defects

Nature reviews. Immunology, 2004-12, Vol.4 (12), p.941-952

Gabrilovich, Dmitry

2004

Volltextzugriff (PDF)

Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells

The Journal of immunology (1950), 2001-05, Vol.166 (9), p.5398-5406

2001

Volltextzugriff (PDF)

Antibodies to Vascular Endothelial Growth Factor Enhance the Efficacy of Cancer Immunotherapy by Improving Endogenous Dendritic Cell Function

Clinical cancer research, 1999-10, Vol.5 (10), p.2963-2970

1999

Volltextzugriff (PDF)

Decreased antigen presentation by dendritic cells in patients with breast cancer

Clinical cancer research, 1997-03, Vol.3 (3), p.483-490

1997

Volltextzugriff (PDF)

Clinical Significance of Defective Dendritic Cell Differentiation in Cancer

Clinical cancer research, 2000-05, Vol.6 (5), p.1755-1766

2000

Volltextzugriff (PDF)

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

Nature medicine, 1996-10, Vol.2 (10), p.1096-1103

1996

Volltextzugriff (PDF)

Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells

The Journal of immunology (1950), 1998-02, Vol.160 (3), p.1224-1232

1998

Volltextzugriff (PDF)

Combination of γ‐irradiation and dendritic cell administration induces a potent antitumor response in tumor‐bearing mice: Approach to treatment of advanced stage cancer

International journal of cancer, 2001-12, Vol.94 (6), p.825-833

2001

Volltextzugriff (PDF)

An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53

Gene therapy, 2002-03, Vol.9 (5), p.345-352

2002

Volltextzugriff (PDF)

Induction of Potent Human Immunodeficiency Virus Type 1-Specific T-Cell-Restricted Immunity by Genetically Modified Dendritic Cells

Journal of Virology, 2001-08, Vol.75 (16), p.7621-7628

2001

Volltextzugriff (PDF)

Defective Function of Langerhans Cells in Tumor-Bearing Animals Is the Result of Defective Maturation from Hemopoietic Progenitors

The Journal of immunology (1950), 1998-11, Vol.161 (9), p.4842-4851

1998

Volltextzugriff (PDF)

Dendritic cells transduced with wild‐type p53 gene elicit potent anti‐tumour immune responses

Clinical and experimental immunology, 1999-08, Vol.117 (2), p.244-251

1999

Volltextzugriff (PDF)

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

Nature medicine, 2004-01, Vol.10 (1), p.48-54

2004

Volltextzugriff (PDF)

Abstract BS1-2: Myeloid-derived suppressor cells: many facets of regulation of tumor progression

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.BS1-2-BS1-2

Gabrilovich, DI

2018

Volltextzugriff (PDF)

Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells

The Journal of experimental medicine, 2015-03, Vol.212 (3), p.351-367

2015

Volltextzugriff (PDF)

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

The Journal of clinical investigation, 2010-04, Vol.120 (4), p.1111-1124

2010

Volltextzugriff (PDF)

Hyperactivation of STAT3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer

The Journal of immunology (1950), 2004-01, Vol.172 (1), p.464-474

2004

Volltextzugriff (PDF)

STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion

The Journal of immunology (1950), 2005-04, Vol.174 (8), p.4880-4891

2005

Volltextzugriff (PDF)

Highlights of 10 years of immunology in Nature Reviews Immunology

Nature reviews. Immunology, 2011-10, Vol.11 (10), p.693-702

2011

Volltextzugriff (PDF)

39 Myeloid-derived suppressor cells (MDSC) are effectors of bone marrow suppression in lower risk myelodysplastic syndromes (MDS)

Leukemia research, 2011, Vol.35, p.S13-S13

2011

Volltextzugriff (PDF)

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination

Cancer research (Chicago, Ill.), 2003-08, Vol.63 (15), p.4441-4449

2003

Volltextzugriff (PDF)

Dendritic Cells in Antitumor Immune Responses: I. Defective Antigen Presentation in Tumor-Bearing Hosts

Cellular immunology, 1996-05, Vol.170 (1), p.101-110

1996

Volltextzugriff (PDF)

Effect of Vascular Endothelial Growth Factor and FLT3 Ligand on Dendritic Cell Generation In Vivo

The Journal of immunology (1950), 1999-09, Vol.163 (6), p.3260-3268

1999

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(153)
Tagungsberichte
(1)

Sprache

Englisch
(129)
Russisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Redox phospholipidomics of enzymatically generated oxygenated phospholipids as specific signals of programmed cell death

Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer

Mechanisms and functional significance of tumour-induced dendritic-cell defects

Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells

Antibodies to Vascular Endothelial Growth Factor Enhance the Efficacy of Cancer Immunotherapy by Improving Endogenous Dendritic Cell Function

Decreased antigen presentation by dendritic cells in patients with breast cancer

Clinical Significance of Defective Dendritic Cell Differentiation in Cancer

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells

Combination of γ‐irradiation and dendritic cell administration induces a potent antitumor response in tumor‐bearing mice: Approach to treatment of advanced stage cancer

An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53

Induction of Potent Human Immunodeficiency Virus Type 1-Specific T-Cell-Restricted Immunity by Genetically Modified Dendritic Cells

Defective Function of Langerhans Cells in Tumor-Bearing Animals Is the Result of Defective Maturation from Hemopoietic Progenitors

Dendritic cells transduced with wild‐type p53 gene elicit potent anti‐tumour immune responses

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

Abstract BS1-2: Myeloid-derived suppressor cells: many facets of regulation of tumor progression

Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

Hyperactivation of STAT3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer

STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion

Highlights of 10 years of immunology in Nature Reviews Immunology

39 Myeloid-derived suppressor cells (MDSC) are effectors of bone marrow suppression in lower risk myelodysplastic syndromes (MDS)

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination

Dendritic Cells in Antitumor Immune Responses: I. Defective Antigen Presentation in Tumor-Bearing Hosts

Effect of Vascular Endothelial Growth Factor and FLT3 Ligand on Dendritic Cell Generation In Vivo

Suchergebnisse filtern